Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email